A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus

INTRODUCTION: Comparisons between brand and biosimilar basal insulin in hospitalized patients are lacking. We aimed to compare the efficacy and safety of brand insulin glargine vs. biosimilar insulin glargine in non-critical hospitalized patients with type 2 diabetes mellitus (T2DM). METHODS: This r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xia, Zhang, Lei, Dong, Chao, Dong, Yanhu, Jiang, Jikang, Gao, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824369/
https://www.ncbi.nlm.nih.gov/pubmed/30900200
http://dx.doi.org/10.1007/s12325-019-00922-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824369/
https://www.ncbi.nlm.nih.gov/pubmed/30900200
http://dx.doi.org/10.1007/s12325-019-00922-9

Ejemplares similares